Abstract
Antisense oligonucleotide (AON)-mediated exon skipping is a therapeutic approach for subsets of Duchenne muscular dystrophy (DMD) patients to ameliorate the severe DMD phenotype. Several groups have successfully induced exon skipping by AONs to reframe the mRNA in various patients carrying deletions, and phase I/II clinical trials are ongoing. The approach is based on targeting specific splicing motifs, both exonic and located on the exon borders, thus interfering with the spliceosome assembly by steric hindrance. Evaluation of the effectiveness of treatment with AONs in cells, animal models, and humans requires a sensitive, specific, and highly reproducible method. We have developed a real-time PCR-based protocol that uses the probe-based approach to recognize specific sequences internal to the target exon (exon-specific real-time assay). The methods for this protocol are described in this chapter.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Thörn I, Botling J, Hermansson M, Lönnerholm G, Sundström C, Rosenquist R et al (2009) Monitoring minimal residual disease with flow cytometry, antigen-receptor gene rearrangements and fusion transcript quantification in Philadelphia-positive childhood acute lymphoblastic leukemia. Leuk Res 33:1047–1054
Sellars MJ, Vuocolo T, Leeton LA, Coman GJ, Degnan BM, Preston NP (2007) Real-time RT-PCR quantification of Kuruma shrimp transcripts: a comparison of relative and absolute quantification procedures. J Biotechnol 129:391–399
Gutiérrez MI, Timson G, Siraj AK, Bu R, Barbhaya S, Banavali S et al (2005) Single monochrome real-time RT-PCR assay for identification, quantification, and breakpoint cluster region determination of t(9;22) transcripts. J Mol Diagn 7:40–47
Altarescu G, Eldar-Geva T, Varshower I, Brooks B, Haran EZ, Margalioth EJ et al (2009) Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of de novo mutations. Hum Reprod 24:3225–3229
Spitali P, Rimessi P, Fabris M, Perrone D, Falzarano S, Bovolenta M et al (2009) Exon skipping-mediated dystrophin reading frame restoration for small mutations. Hum Mutat 30:1527–1534
Ferlini A, Sabatelli P, Fabris M, Bassi E, Falzarano S, Vattemi G et al (2010) Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes. Gene Ther 17:432–438
Rimessi P, Sabatelli P, Fabris M, Braghetta P, Bassi E, Spitali P et al (2009) Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse. Mol Ther 88:17–24
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Ferlini, A., Rimessi, P. (2012). Exon Skipping Quantification by Real-Time PCR. In: Aartsma-Rus, A. (eds) Exon Skipping. Methods in Molecular Biology, vol 867. Humana Press. https://doi.org/10.1007/978-1-61779-767-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-61779-767-5_12
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-766-8
Online ISBN: 978-1-61779-767-5
eBook Packages: Springer Protocols